HOME

Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 | New England Journal of Medicine

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial - The Lancet Regional Health – Western Pacific

First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan - JTO Clinical and Research Reports

Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC - Journal of Thoracic Oncology

商品説明・詳細
送料・お届け

商品情報

Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 | New England Journal of Medicine,Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial - The Lancet Regional Health – Western Pacific,First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan - JTO Clinical and Research Reports,IMbrave150 efficacy results: Coprimary endpoints | TECENTRIQ® (atezolizumab),Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC - Journal of Thoracic Oncology

残り 1 点 9150円

（11 ポイント還元！）

翌日お届け可（営業日のみ） ※一部地域を除く

お届け日: 03月23日〜指定可お届け日: (明日12:00のご注文まで)

ラッピング

対応決済方法

クレジットカード
コンビニ前払い決済
代金引換: 商品到着と引き換えにお支払いいただけます。 (送料を含む合計金額が￥299,000 まで対応可能)
ペイジー前払い決済(ATM/ネットバンキング): 以下の金融機関のATM/ネットバンクからお支払い頂けます
みずほ銀行、三菱ＵＦＪ銀行、三井住友銀行
りそな銀行、ゆうちょ銀行、各地方銀行
Amazon Pay(Amazonアカウントでお支払い)